Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia

Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia

Abstract Background Psoriasis, an immune-mediated chronic inflammatory disease primarily affecting skin and joints, has varying prevalence rates globally. It manifests in five types, with chronic plaque psoriasis being the most common. Treatment, which has no definitive cure, aims for complete resol...

Full description

Bibliographic Details
Main Authors: Yazed AlRuthia, Almaha H. Alfakhri, Ibtisam Alharbi, Fadi Ali Alghamdi, Miteb A. Alanazi, Abdullah Abdulrahman Alrabiah, Anwar Abdulrazzag Alsouan, Abdulrahman Abdullah Alshaikh, Majed Ali Almasaoud
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Psoriasis
Biologics
Effectiveness
Online Access:https://doi.org/10.1186/s12962-023-00504-1

Internet

https://doi.org/10.1186/s12962-023-00504-1

Similar Items